IntelGenx Technologies Corp.: debt financing — IntelGenx enters amended loan with ATAI; gets $1M now, $1M milestone loan; issues 4M warrants

IntelGenx Technologies Corp.

New $1M First Tranche loan disbursed within 3 business days of March 11; $1M Second Tranche tied to successful VLS-01 OTF Ph1 readout.
Conversion price for First Tranche set at US$0.185/share; Second Tranche uses greater of $0.185 or 5-day VWAP less max TSX discount.
4,000,000 warrants issued to ATAI at US$0.17/share, exercisable for 36 months; all securities unregistered under Section 4(a)(2).
Existing loans amended and restated; Additional Term Loans mature Feb 1, 2026; interest at 14% per annum on new loans.
Proceeds used for general corporate purposes, working capital, R&D.

item 1.01 item 2.03 item 3.02

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

IntelGenx Technologies Corp. incurred term loan of US$1,000,000 with ATAI Life Sciences AG maturing February 1, 2026.

Instrument: term loan
Principal: US$1,000,000
Counterparty: ATAI Life Sciences AG
Maturity: February 1, 2026
Event: incurrence

Exact text from the filing

(i) one (1) additional term loan in the amount of US$1,000,000 to IntelGenx Corp., which loan is to be disbursed within three (3) business days of the execution of the Loan Agreement (the " First Tranche Loan ")

View on SEC.gov

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

IntelGenx Technologies Corp. incurred term loan of US$1,000,000 with ATAI Life Sciences AG maturing February 1, 2026.

Instrument: term loan
Principal: US$1,000,000
Counterparty: ATAI Life Sciences AG
Maturity: February 1, 2026
Event: incurrence

Exact text from the filing

(ii) one (1) additional term loan in the amount of US$1,000,000 to IntelGenx Corp., which loan is to be disbursed upon the achievement of a pre-defined milestone (the " Second Tranche Loan "

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

IntelGenx Technologies Corp. amended Third Amended and Restated Loan Agreement with ATAI Life Sciences AG (effective 2024-03-11).

Action: amendment
Agreement: credit facility
Counterparty: ATAI Life Sciences AG
Effective: 2024-03-11

Exact text from the filing

IntelGenx Technologies Corp. (the " Corporation ") entered into a Third Amended and Restated Loan Agreement dated March 11, 2024 (the " Loan Agreement ") with its wholly-owned subsidiary, IntelGenx Corp., and ATAI Life Sciences AG (" atai "), which amends and restates the Second Amended and Restated Loan Agreement

View on SEC.gov

299 debt financings filed in the last 30 days. Browse all debt financings →

Source: SEC EDGAR

accession 0001062993-24-007044

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.